UPA Vaginal Ring

Product Overview

Alternative Name: Ulipristal acetate (UPA) vaginal ring

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Vaginal Ring

Duration Type: Long-acting

Description: A vaginal ring that delivers ulipristal acetate (UPA) daily. UPA is a progesterone receptor modulator (PMR) approved for use by the US FDA as an oral emergency contraceptive pill (EllaOne) and in the EU for uterine fibroid treatment. Ring is a silicone elastomer fusion technology of a ring within a ring.

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Late Development

Project Stage: Phase II

Began discovery in: 2001

Status Details:
  • Phase IIa dose-finding study has been completed. Effective dose identified. Additional long-term studies to confirm safety in preparation.

Download Product Report